It's Celgene versus Bristol-Myers Squibb in a head-to-head matchup. Which drug stock wins as the better pick for long-term investors?
B.C 's uncertain political future isn't slowing down Kinder Morgan's efforts to push forward the Trans Mountain pipeline expansion - but experts say the project will still have to navigate a political minefield.
LogMeIn logo News articles about LogMeIn (NASDAQ:LOGM) have trended positive on Sunday, according to AlphaOne. The research group, a service of Accern, ranks the sentiment of news coverage by monitoring more than 20 million blog and news ...
Qualcomm agreed to pay BlackBerry $940 million by May 31. This is to refund BlackBerry's overpayment of royalty fees and to cover legal expenses.
Biogen logo Biogen Inc (NASDAQ:BIIB) was downgraded by Vetr from a “strong-buy” rating to a “buy” rating in a report released on Tuesday, May 2nd.